LENZ Therapeutics, Inc.LENZNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank67
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-45.22M
Near historical average
Percentile
P67
Within normal range
Streak
3 yr
Consecutive growthContracting
Average
$-44.94M
Historical baseline
PeriodValueYoY Change
TTM$-45.22M+23.9%
2024$-59.39M+1.6%
2023$-60.38M+31.4%
2022$-87.98M-66.5%
2021$-52.85M-506.0%
2020$-8.72M-45800.0%
2019$-19000.00-